This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Deutschland Krebsforschungszentrum. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Ulrike Litzenburger: Innovator in Cancer Therapeutics
Introduction
Ulrike Litzenburger is a prominent inventor based in Dossenheim, Germany. She has made significant contributions to the field of cancer therapeutics, particularly in the treatment and prevention of natural AHR ligand-dependent cancers. Her innovative approach has the potential to impact many lives.
Latest Patents
Ulrike holds a patent titled "Means and methods for treating and/or preventing natural AHR ligand-dependent cancer." This invention focuses on a method for treating and preventing such cancers by administering a therapeutically effective amount of an AHR inhibitor to affected subjects. The patent highlights the importance of AHR inhibitors in cancer treatment, showcasing her commitment to advancing medical science.
Career Highlights
Ulrike Litzenburger is affiliated with the German Cancer Research Center (Deutsches Krebsforschungszentrum), where she conducts her research. Her work is characterized by a dedication to understanding cancer mechanisms and developing effective therapeutic strategies.
Collaborations
Ulrike collaborates with esteemed colleagues, including Michael Platten and Christiane Opitz. These partnerships enhance her research efforts and contribute to the advancement of cancer treatment methodologies.
Conclusion
Ulrike Litzenburger's innovative work in cancer therapeutics exemplifies her dedication to improving patient outcomes. Her patent on AHR inhibitors represents a significant step forward in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile